Literature DB >> 12426687

Subacute leukencephalopathy after low-dose intrathecal methotrexate in an adolescent heterozygous for the MTHFR C677T polymorphism.

Tobias Strunk1, Stefan Gottschalk, Wolfgang Goepel, Peter Bucsky, Christian Schultz.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12426687     DOI: 10.1002/mpo.10192

Source DB:  PubMed          Journal:  Med Pediatr Oncol        ISSN: 0098-1532


× No keyword cloud information.
  5 in total

1.  Diffusion-weighted MRI correlates of subacute methotrexate-related neurotoxicity.

Authors:  M E Haykin; M Gorman; J van Hoff; R K Fulbright; J M Baehring
Journal:  J Neurooncol       Date:  2006-01       Impact factor: 4.130

2.  Diffusion-weighted MRI correlates of subacute methotrexate-related neurotoxicity.

Authors:  Me Haykin; M Gorman; J van Hoff; Rk Fulbright; Jm Baehring
Journal:  J Neurooncol       Date:  2006-01       Impact factor: 4.130

3.  Leukoencephalopathy due to oral methotrexate.

Authors:  I González-Suárez; M J Aguilar-Amat; M Trigueros; A M Borobia; A Cruz; J Arpa
Journal:  Cerebellum       Date:  2014-02       Impact factor: 3.847

4.  Impact of genetic polymorphisms on chemotherapy toxicity in childhood acute lymphoblastic leukemia.

Authors:  Guillermo Gervasini; Jose M Vagace
Journal:  Front Genet       Date:  2012-11-22       Impact factor: 4.599

5.  Methotrexate induced leucoencephalopathy: A stroke mimic.

Authors:  Tushar D Gosavi; Mohammed Tauqeer Ahmad; Lai-Heng Lee; Shih-Hui Lim
Journal:  Ann Indian Acad Neurol       Date:  2013-07       Impact factor: 1.383

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.